Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-02

Clinical Trial Update: TMC207-TiDP13-C117: Interaction Study in Human Immunodeficiency Virus-type 1 (HIV-1) Infected Patients With Nevirapine (NVP) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating potential drug–drug interaction between TMC207-TiDP13-C117 and nevirapine in HIV-1-infected patients; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEVIRAPINE (nevirapine)
  • bedaquiline (bedaquiline)

Snippet

Sponsor: Tibotec BVBA | Conditions: HIV Infections | Phase 1 | Status: COMPLETED